<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-56921" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pemphigus Vegetans</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Messersmith</surname>
            <given-names>Lynn</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krauland</surname>
            <given-names>Kevin</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lynn Messersmith declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kevin Krauland declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-56921.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pemphigus is a group of vesiculobullous autoimmune diseases. The most common type of pemphigus is pemphigus vulgaris, characterized by mucocutaneous bullae. Among the many types of pemphigus, the rarest clinical variant is pemphigus vegetans. It distinguishes itself from pemphigus vulgaris by the formation of vegetative plaques in intertriginous areas and oral mucosa. Thought to be a subtype of pemphigus vulgaris, pemphigus vegetans represents 1% to 2% of all pemphigus. This activity highlights the presentation and diagnosis of pemphigus vegetans, a rare variant of autoimmune pemphigus, and emphasizes the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of pemphigus vegetans.</p></list-item><list-item><p>Explain the history and physical exam of a patient with pemphigus vegetans.</p></list-item><list-item><p>Outline the treatment and management options available for pemphigus vegetans.</p></list-item><list-item><p>Review interprofessional team strategies for improving care coordination and communication to advance pemphigus vegetans and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=56921&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=56921">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-56921.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pemphigus is a group of vesiculobullous autoimmune diseases. The most common type of pemphigus is pemphigus vulgaris, characterized by mucocutaneous bullae.<xref ref-type="bibr" rid="article-56921.r1">[1]</xref>&#x000a0;Among the many types of pemphigus, the rarest clinical variant is pemphigus vegetans. It distinguishes itself from pemphigus vulgaris by the formation of vegetative plaques in intertriginous areas and oral mucosa. Thought to be a subtype of pemphigus vulgaris, pemphigus vegetans represents 1-2% of all pemphigus&#x000a0;<xref ref-type="bibr" rid="article-56921.r2">[2]</xref>. It is often difficult to diagnose and clinically misleading due to the variable presentation and presence of verrucous vegetations.<xref ref-type="bibr" rid="article-56921.r3">[3]</xref>&#x000a0;There are two clinically recognized forms of pemphigus vegetans: the Hallopeau and Neumann. The Hallopeau type has an indolent course and characteristically demonstrates pustules that heal as vegetative plaques. The Neumann type is more severe and refractory to treatment, with vegetations that develop during an eruption of vesiculobullous lesions. The oral mucosa is usually involved.<xref ref-type="bibr" rid="article-56921.r4">[4]</xref>&#x000a0;The most common cause of pemphigus vegetans is autoantibodies against desmoglein 3 (DSG3) and desmoglein 1 (DSG1).<xref ref-type="bibr" rid="article-56921.r5">[5]</xref>&#x000a0;The mainstay of treatment for pemphigus vegetans is similar to that of pemphigus vulgaris, consisting of systemic corticosteroids and immunosuppressants.<xref ref-type="bibr" rid="article-56921.r2">[2]</xref></p>
      </sec>
      <sec id="article-56921.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pemphigus vegetans results from autoantibodies against the transmembrane proteins that comprise desmosomes, which are responsible for keratinocyte cell-to-cell adhesion. Specifically, pemphigus vegetans is most commonly caused by autoantibodies against desmoglein 3 and often desmoglein 1.<xref ref-type="bibr" rid="article-56921.r5">[5]</xref>&#x000a0;Mucosal dominant disease is more frequently associated with desmoglein 3, and mucocutaneous disease is associated with autoantibodies against both desmoglein 3 and desmoglein 1. IgG and IgA antibodies against desmocollins are also present in patients with pemphigus vegetans.<xref ref-type="bibr" rid="article-56921.r6">[6]</xref></p>
      </sec>
      <sec id="article-56921.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The epidemiology of pemphigus vegetans has not been a topic of research. Reports are that it represents 1 to 2% of all pemphigus cases, and worldwide, the incidence of pemphigus vulgaris is approximately 0.7 per 100000. Given the limited cases, the epidemiology is thought to be similar to pemphigus vulgaris, which occurs more frequently in women, with a female-to-male ratio of between 1.3 and 2.3 to 1. Age at diagnosis is typically 50 to 70 years in the United States and European countries and 30 to 50 years in the remaining countries. Pemphigus vulgaris is reportedly more common among the Ashkenazi Jewish, Mediterranean, and Middle Eastern populations.<xref ref-type="bibr" rid="article-56921.r7">[7]</xref><xref ref-type="bibr" rid="article-56921.r8">[8]</xref></p>
      </sec>
      <sec id="article-56921.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of pemphigus is characterized by IgG autoantibodies against the components of desmosomes that are responsible for keratinocyte adhesion, specifically desmoglein 3 and desmoglein 1. Autoantibody binding to desmogleins has been shown to cause blistering through several mechanisms- including steric hindrance, interruption of desmosome assembly and/or increased breakdown, and secondary activation of signal transduction events involving keratinocyte adhesion. Structural studies suggest steric hindrance from the molecular structure of the desmoglein-antibody complex creates the intraepidermal spaces that result in spongiosis and blister formation. These studies also show&#x000a0;anti-desmoglein 3 antibodies present deep in the epidermis with concentrations of anti-desmoglein 1 antibodies in the upper epidermis.<xref ref-type="bibr" rid="article-56921.r9">[9]</xref><xref ref-type="bibr" rid="article-56921.r5">[5]</xref>&#x000a0;</p>
        <p>Autoantibody deposition against desmogleins within the epidermal space and on the outer surface of keratinocytes leads to acute inflammation and blister formation. In pemphigus vegetans, in addition to desmogleins 1 and 3, there are frequently antibodies to desmocollins 1 and 2. The addition of these antibodies has been suggested as an etiology for the difference in clinical appearance between pemphigus vulgaris and pemphigus vegetans and have been known to synergize with anti-desmoglein 3 antibodies to induce acantholysis.<xref ref-type="bibr" rid="article-56921.r10">[10]</xref>&#x000a0;It is still unknown how the characteristic vegetative lesions form following blister formation. Associated factors are thought to include semi-occlusion or maceration due to intertriginous location. Other theories suggest vegetative plaques form after serial bacterial or fungal infections as a protective response.</p>
        <p>Genetics</p>
        <p>There is a known component of genetic susceptibility to pemphigus. Studies have shown that certain human leukocyte antigen (HLA) alleles may be responsible for increased autoantibody formation against desmogleins. Mapping of the major histocompatibility complex region of chromosome 11 has shown an association between pemphigus vulgaris and HLA-DRB1 and HLA-DQB1, with the strongest association between HLA-DQB1*05:03.<xref ref-type="bibr" rid="article-56921.r11">[11]</xref>&#x000a0;In addition to increased genetic susceptibility, there is a hypothesis that B cells with VH1-46 heavy chain gene usage may be hypersensitive to desmoglein 3, increasing cellular damage.<xref ref-type="bibr" rid="article-56921.r12">[12]</xref><xref ref-type="bibr" rid="article-56921.r13">[13]</xref><xref ref-type="bibr" rid="article-56921.r14">[14]</xref></p>
      </sec>
      <sec id="article-56921.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Classical histologic findings in pemphigus vegetans include hyperkeratosis, pseudoepitheliomatous hyperplasia, and papillomatosis, with acantholysis that creates a suprabasal cleft. The basal cells maintain their attachment to the basement membrane by intact hemidesmosomes, creating the characteristic appearance of &#x0201c;tombstones.&#x0201d; Follicular involvement is a frequent occurrence. Especially in the Hallopeau type, there is a strong eosinophilic response, with eosinophilic spongiosis, intraepidermal eosinophilic microabscesses, and dense eosinophilic dermal infiltrate. Neutrophils and lymphocytes usually accompany the eosinophilic response and are more likely to be the primary inflammatory component in the Neumann type. There may be papillary dermis edema to the heavy inflammatory infiltrate.<xref ref-type="bibr" rid="article-56921.r4">[4]</xref></p>
      </sec>
      <sec id="article-56921.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The majority of patients initially present to their provider with stomatitis.<xref ref-type="bibr" rid="article-56921.r15">[15]</xref>&#x000a0;A few weeks to months after the mucosal blisters, cutaneous pustules and/or flaccid bullae form, typically affecting the trunk, arms, legs, and flexural areas. The Hallopeau subtype characteristically demonstrates initial pustular lesions and has a more indolent course. The Neumann subtype has characteristic large vesiculobullous erosive lesions and is more severe. The cutaneous lesions rupture and ulcerate, and verrucous, crusting vegetative plaques form over the erosions. These hyperkeratotic lesions characteristically present in the intertriginous areas- including the groin/inguinal folds, armpits, thighs, and flexural surfaces.<xref ref-type="bibr" rid="article-56921.r5">[5]</xref>&#x000a0;Less common areas affected include the scalp, soles of the feet, and skin graft sites. There are also reports of nasal, vaginal, and conjunctival involvement.<xref ref-type="bibr" rid="article-56921.r16">[16]</xref><xref ref-type="bibr" rid="article-56921.r17">[17]</xref>&#x000a0;In the oral cavity, the hyperkeratotic plaques appear on the tongue in a cerebriform pattern.</p>
        <p>Although most patients present with pertinent physical exam findings, it is important to take a detailed history- including a family and personal history of autoimmune disease and skin problems. Other relevant details include stressors, history of radiation, recent illness, changes in medications, or if there is pain associated with activities such as eating, swallowing, sexual activity, or if the symptoms flare with menstruation.<xref ref-type="bibr" rid="article-56921.r18">[18]</xref></p>
      </sec>
      <sec id="article-56921.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of pemphigus vegetans is made based on clinical features, histologic examination, and identification of autoantibodies. There are several methods to evaluate and identify autoantibodies.<xref ref-type="bibr" rid="article-56921.r19">[19]</xref>&#x000a0;</p>
        <p>Immunoblot or ELISA analysis of serum:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood tests can identify patients with desmoglein 3 autoantibodies in their serum with a specificity and sensitivity of 98 to 100%, so nearly all patients with pemphigus will have detectable desmoglein 3 reactivity, and unaffected individuals will not.<xref ref-type="bibr" rid="article-56921.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Direct Immunofluorescence (DIF):</p>
        <list list-type="bullet">
          <list-item>
            <p>Similar to pemphigus vulgaris, the direct immunofluorescence findings in pemphigus vegetans show intercellular deposition of IgG and C3 within the intraepidermal space and on the surface of keratinocytes. IgG4 and IgG1 are the predominant types of IgG involved. This deposition creates a characteristic &#x0201c;fishnet&#x0201d; or &#x0201c;chicken wire&#x0201d; pattern.<xref ref-type="bibr" rid="article-56921.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>For optimal DIF evaluation, a punch biopsy or deep shave from normal-appearing peri-lesional skin should be submitted in Michel&#x02019;s solution (or fixative appropriate for DIF).</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>Serum immunoglobulins: IgG and IgA titers are often correlated with disease activity and can be used to follow therapeutic response.</p>
        <p>Less commonly used methods of evaluation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Indirect immunofluorescence (IIF) is a semi-quantitative method for identifying autoantibodies.</p>
          </list-item>
          <list-item>
            <p>Electron microscopy: Keratinocytes show a reduction of tonofilaments. Only rarely are there desmosomes identified. The basement membrane often appears damaged as a result of inflammatory infiltrates.<xref ref-type="bibr" rid="article-56921.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>Additional methods for evaluation:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nikolsky sign: Side pressure on the blister leads to blister extension. Often positive; however, this test is non-specific and seen in several blistering skin diseases.</p>
          </list-item>
          <list-item>
            <p>Tzanck test: Cutaneous cytology is useful to rule out pemphigus; however, the diagnosis should be by clinical exam, histopathology, and antibody identification. The reported sensitivity and specificity of a Tzanck smear is 85.0% and 83.33% for pemphigus.<xref ref-type="bibr" rid="article-56921.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Complete blood count with differential: May show peripheral eosinophilia.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-56921.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Wound Care: Daily cleansing and dressing. Medicated gauzes and chemical cautery.<xref ref-type="bibr" rid="article-56921.r22">[22]</xref></p>
        <p>Surgical options: Surgical excision of vegetative lesions.<xref ref-type="bibr" rid="article-56921.r22">[22]</xref></p>
        <p>Treatment for Oral Involvement: Magic mouthwash comprised of liquid dexamethasone; 5 cc rinse, 2x per day, or clobetasol ointment.</p>
        <p>Topical Options<xref ref-type="bibr" rid="article-56921.r23">[23]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Class I steroids are applied twice daily</p>
          </list-item>
          <list-item>
            <p>Topical tacrolimus for facial involvement or if sensitive to chronic steroid therapy</p>
          </list-item>
          <list-item>
            <p>Minocycline/nicotinamide at onset and relapse has been used with success and avoids systemic steroids</p>
          </list-item>
        </list>
        <p>Intralesional Therapy:</p>
        <list list-type="bullet">
          <list-item>
            <p>Triamcinolone is injected directly into refractory vegetative lesions</p>
          </list-item>
        </list>
        <p>Systemic Therapy: The gold standard for treatment is systemic corticosteroids. Corticosteroids are thought to upregulate desmoglein expression in keratinocytes, resulting in rapid therapeutic effect. Corticosteroids and immunosuppressants are the most effective in managing patients with pemphigus.<xref ref-type="bibr" rid="article-56921.r24">[24]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Prednisone: 0.5 to 2 mg/kg/day for 2 to 4 weeks.</p>
          </list-item>
          <list-item>
            <p>Azathioprine: 50 mg daily; upwards titrate to 2.5 mg/kg/day.</p>
          </list-item>
          <list-item>
            <p>Dapsone: 100 to 200mg daily. Ideal for mucosal involvement. It may combine with mycophenolate or azathioprine.<xref ref-type="bibr" rid="article-56921.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>Mycophenolate mofetil: 30 to 40 mg/kg/day. Risk of side effects, lymphoma, and JC virus.</p>
          </list-item>
          <list-item>
            <p>Methotrexate: 15 mg/week. Safe and beneficial steroid-sparing agent.<xref ref-type="bibr" rid="article-56921.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Cyclophosphamide: Works&#x000a0;well for oral mucosa but has an extensive side effect profile.</p>
          </list-item>
          <list-item>
            <p>First-line combination therapies:
<list list-type="bullet"><list-item><p>Corticosteroids plus one of the following agents: rituximab, mycophenolate mofetil, azathioprine, methotrexate, cyclophosphamide, or IVIG.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>If standard steroids and immunosuppressants are not sufficient, second-line treatments include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Rituximab, an anti-CD20 monoclonal antibody, with or without IVIG, dosed at 2 mg/kg over 3 to 5 days every 4 weeks. Rituximab has been shown to elucidate short-term remission in 95% to 100% of pemphigus patients and correlates with a decrease in anti-DSG3 titers.<xref ref-type="bibr" rid="article-56921.r10">[10]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pulse&#x000a0;Therapy: &#x000a0;Intermittent high-dose IV corticosteroids and immunosuppressive agents to achieve faster results and minimize side effects of long-term steroid therapy.<xref ref-type="bibr" rid="article-56921.r27">[27]</xref></p>
          </list-item>
        </list>
        <p>The recommendation is to maintain remission for 1 year and then slowly taper therapy over another year, tailored to the individual patient and their comorbidities.</p>
        <p>Less common treatment options include plasmapheresis, immunoadsorption, and hematopoietic stem cell transplant.<xref ref-type="bibr" rid="article-56921.r24">[24]</xref></p>
        <p>Emerging Therapies: The goal is to offer long-term therapy with fewer side effects and less systemic immunosuppression.</p>
        <list list-type="bullet">
          <list-item>
            <p>B cell-activating factor (BAFF): B-cell-activating factor co-stimulates B-cell responses. Patients with B-cell-mediated autoimmune diseases often have increased BAFF, which makes it a novel therapeutic target.<xref ref-type="bibr" rid="article-56921.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Proliferation-inducing ligand (APRIL) inhibitors: Proliferation-inducing ligand is a key biomarker in the regulation of B-cells, humoral immunity, and pathogenicity of autoimmune disease. Inhibitors are a therapeutic option.<xref ref-type="bibr" rid="article-56921.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Anti-cytokine&#x000a0;therapy, anti-interleukin (IL)-4 and anti-interleukin (IL)-6): Interleukins, particularly IL-4, and IL-6, have been implicated in pemphigus by exacerbating Th2 overexpression and isotype switching to IgG1 and IgG4, which have been shown to play a role in the loss of desmoglein. Direct inhibition of IL-4 and IL-6 is a potential treatment for patients with pemphigus.<xref ref-type="bibr" rid="article-56921.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Co-stimulatory and co-inhibitors- manipulators and inhibitors of pathogenic signaling pathways (p38MAPK, c-Myc, and EGFR)&#x000a0;are currently being studied and may be targets for novel therapies.<xref ref-type="bibr" rid="article-56921.r31">[31]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-56921.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Pyodermatitis pyostomatitis vegetans: Clinically and histologically look similar to pemphigus vegetans but is often associated with inflammatory bowel disease and should have a negative DIF.<xref ref-type="bibr" rid="article-56921.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>Bullous pemphigoid: Typically presents with tense blisters, urticarial plaques, and pruritus. Mucosal involvement is rare. The histopathological evaluation shows a subepidermal cleft, and DIF shows IgG and/or C3 deposition at the basement membrane. Circulating IgG and IgE autoantibodies are detected against hemidesmosomal proteins.<xref ref-type="bibr" rid="article-56921.r33">[33]</xref><xref ref-type="bibr" rid="article-56921.r34">[34]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>IgA pemphigus: A subacute autoimmune intraepidermal blistering disease associated with circulating IgA antibodies. DIF shows intracellular IgA deposits within the epidermis.<xref ref-type="bibr" rid="article-56921.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Hailey-Hailey Disease: Hailey-Hailey disease is an autosomal dominant genodermatosis that often forms chronic inflammatory plaques in intertriginous areas. The plaques appear as crusted macerated erosions with dry, velvety fissures. Histologic evaluation of the epidermis demonstrates the characteristic &#x0201c;dilapidated brick wall&#x0201d; appearance, which consists of suprabasal clefting and acantholysis.<xref ref-type="bibr" rid="article-56921.r36">[36]</xref><xref ref-type="bibr" rid="article-56921.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Pyoderma vegetans: Rare vesiculopustular disease characterized by vegetative plaques with exudate, classically located in the inguinal and axillary folds. It is generally found in immunocompromised patients and is associated with bacterial infections. Histologically, there is pseudoepitheliomatous hyperplasia with sub and intraepidermal microabscesses.<xref ref-type="bibr" rid="article-56921.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Paraneoplastic pemphigus: Similar findings to pemphigus vulgaris, often with severe mucosal involvement. It is always associated with underlying malignancy, most commonly a hematopoietic malignancy such as chronic lymphocytic leukemia or other B-cell lymphomas.<xref ref-type="bibr" rid="article-56921.r39">[39]</xref> Anti-periplakin is also associated with paraneoplastic pemphigus.<xref ref-type="bibr" rid="article-56921.r5">[5]</xref><xref ref-type="bibr" rid="article-56921.r40">[40]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epidermolysis bullosa acquisita (EBA): EBA is an autoimmune blistering disease with mucosal involvement. It is caused by circulating autoantibodies against type VII collagen, which is responsible for maintaining the dermal-epidermal junction. The clinical picture is variable, and linear deposits of IgG, IgA, and/or C3 along the dermal-epidermal junction and identification of serum autoantibodies against type VII collagen confirm the diagnosis.<xref ref-type="bibr" rid="article-56921.r41">[41]</xref></p>
          </list-item>
          <list-item>
            <p>Porphyria: Porphyrias&#x000a0;are genetic diseases of the heme biosynthesis pathway. Porphyria&#x000a0;cutanea&#x000a0;tarda (PCT) is the commonest, characterized by defective uroporphyrinogen III decarboxylase enzyme. Dermatological manifestations include erosions, vesicles, and bullae in areas exposed to sunlight.<xref ref-type="bibr" rid="article-56921.r42">[42]</xref><xref ref-type="bibr" rid="article-56921.r43">[43]</xref></p>
          </list-item>
          <list-item>
            <p>Pemphigus foliaceus (PF): PF is similar to pemphigus vulgaris, but autoantibodies direct their activity against desmoglein (DSG) 1, and it does not involve the mucosal membranes. The blister is often more superficially located in the epidermis.<xref ref-type="bibr" rid="article-56921.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Disseminated Herpes infection May cause vesiculobullous eruptions due to viral infection. Histopathological evaluation, viral studies, and culture are key for diagnosis.<xref ref-type="bibr" rid="article-56921.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): Spectrum of desquamative disorders characterized by prodromal upper respiratory symptoms, followed by a rash that progresses to full or partial thickness epidermal loss. Most often caused by medication, but it has also been associated with infectious etiologies.<xref ref-type="bibr" rid="article-56921.r45">[45]</xref><xref ref-type="bibr" rid="article-56921.r46">[46]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Desquamative gingivitis- may be seen in herpes, oral lichen planus, erythema multiforme, and SJS/TEN.<xref ref-type="bibr" rid="article-56921.r4">[4]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-56921.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Autoimmunity is not curable but rather only treated and managed. If untreated, pemphigus, including pemphigus vegetans, can be fatal within 5 years due to severe blistering, secondary infection, and malnutrition. Mortality is approximately 5% to 15% per year.<xref ref-type="bibr" rid="article-56921.r10">[10]</xref></p>
      </sec>
      <sec id="article-56921.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Secondary infection of lesions: <italic toggle="yes">Staphylococcus aureus</italic>, MRSA, herpes, and fungal organisms are most common.</p>
        <p>There can be increased susceptibility to systemic infection due to chronic use of immunosuppressive therapies.</p>
        <p>Malnutrition due to oral mucosa involvement causes pain, decreased oral intake, and weight loss.</p>
        <p>Pap smears may present as dysplastic due to the appearance of acantholytic cells from the cervical and vaginal mucosa.<xref ref-type="bibr" rid="article-56921.r47">[47]</xref></p>
      </sec>
      <sec id="article-56921.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a dermatologist is the recommended course for diagnosis and management. Patients on long-term corticosteroids may need endocrinology consultation to manage metabolic side effects.</p>
      </sec>
      <sec id="article-56921.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Pemphigus vulgaris has a known association with myasthenia gravis and thymoma, and patients diagnosed with these conditions are more likely to develop pemphigus.<xref ref-type="bibr" rid="article-56921.r48">[48]</xref></p>
        <p>Patients taking penicillamine or ACE inhibitors (particularly captopril and enalapril) are at increased risk of developing pemphigus. The reported prevalence of pemphigus among patients taking penicillamine is around 7%.<xref ref-type="bibr" rid="article-56921.r49">[49]</xref></p>
        <p>There is a known association between intranasal heroin use and pemphigus vegetans.<xref ref-type="bibr" rid="article-56921.r50">[50]</xref></p>
        <p>Special care should be taken not to pop the blisters; no scrubbing or high-pressure water, as this increases the risk of infection.</p>
      </sec>
      <sec id="article-56921.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All autoimmune diseases require an interprofessional approach for appropriate diagnosis and life-long management. Pemphigus vegetans is a unique variant of pemphigus that is often underrecognized and frequently misdiagnosed. Although it is the rarest form of pemphigus, it is potentially fatal if untreated. Healthcare teams need to work together to recognize and treat patients with this rare form of vesiculobullous autoimmune disease. Because the management of these patients is with a variety of immunosuppressive agents, they need to be educated about the adverse effects and lifelong monitoring. Because of the constant state of suppressed immunity, they also develop bacterial and viral infections. Thus, an infectious disease nurse should follow the patient and monitor for signs of an infection. Pharmacists should verify all dosing and perform medication reconciliation, reporting any concerns to the rest of the healthcare team. Corticosteroids may induce diabetes, so an endocrine consult is necessary. Also, these agents may cause bone thinning, so osteoporosis should be screened to prevent fractures. Many patients develop chronic wounds that fail to heal. Therefore, a wound care nurse should educate the patient on wound care. Only through open communication between the team members can the morbidity and mortality of this severe disorder be reduced.</p>
        <p>In summary, pemphigus vulgaris requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, collaborating across disciplines to achieve optimal patient results. [Level 5]</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Unfortunately, despite optimal treatment, the disorder still carries a mortality rate of nearly 10% a year.</p>
      </sec>
      <sec id="article-56921.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=56921&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=56921">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/pemphigus-vegetans/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=56921">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/56921/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=56921">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-56921.s17">
        <title>References</title>
        <ref id="article-56921.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sengupta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Clinicopathological and Immunofluorescence Study of Intraepidermal Immunobullous Diseases.</article-title>
            <source>Indian J Dermatol</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-105</page-range>
            <pub-id pub-id-type="pmid">30983604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von K&#x000f6;ckritz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>St&#x000e4;nder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeidler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Metze</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Luger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bonsmann</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-88</page-range>
            <pub-id pub-id-type="pmid">27600093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mergler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kerstan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goebeler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benoit</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2017</year>
            <season>Jan-Apr</season>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-130</page-range>
            <pub-id pub-id-type="pmid">28559810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jindal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Imchen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Localized Pemphigus Vegetans without Mucosal Involvement.</article-title>
            <source>Indian J Dermatol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>210</fpage>
            <pub-id pub-id-type="pmid">24700958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cozzani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Christana</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mastrogiacomo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rampini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Drosera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murialdo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Parodi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.</article-title>
            <source>Eur J Dermatol</source>
            <year>2007</year>
            <season>Nov-Dec</season>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>530</fpage>
            <page-range>530-3</page-range>
            <pub-id pub-id-type="pmid">17951135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hashimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Higashiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garrod</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Detection of anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis.</article-title>
            <source>J Dermatol Sci</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-6</page-range>
            <pub-id pub-id-type="pmid">8060912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langan</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Smeeth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.</article-title>
            <source>BMJ</source>
            <year>2008</year>
            <month>Jul</month>
            <day>09</day>
            <volume>337</volume>
            <issue>7662</issue>
            <fpage>a180</fpage>
            <pub-id pub-id-type="pmid">18614511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Damstetter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>AYY</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune blistering disorders in the setting of human immunodeficiency virus infection.</article-title>
            <source>Int J Womens Dermatol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-165</page-range>
            <pub-id pub-id-type="pmid">30175218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suwarsa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sutedja</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dharmadji</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Kusuma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rahardja</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hindritiani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gunawan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The Rare Case of Pemphigus Vegetans in Association with Malnutrition Children in the Multidisciplinary Management.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2017</year>
            <season>Jan-Apr</season>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-150</page-range>
            <pub-id pub-id-type="pmid">28559814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellebrecht</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Setting the target for pemphigus vulgaris therapy.</article-title>
            <source>JCI Insight</source>
            <year>2017</year>
            <month>Mar</month>
            <day>09</day>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>e92021</fpage>
            <pub-id pub-id-type="pmid">28289723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-25</page-range>
            <pub-id pub-id-type="pmid">29313220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Foo</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Irwanto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome-wide association and next generation sequence analysis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>410</fpage>
            <page-range>410-415</page-range>
            <pub-id pub-id-type="pmid">30169916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in the understanding and treatment of pemphigus and pemphigoid.</article-title>
            <source>F1000Res</source>
            <year>2018</year>
            <volume>7</volume>
            <pub-id pub-id-type="pmid">30228865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dietze</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hohenstein</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tselmin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Julius</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Beissert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>G&#x000fc;nther</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris.</article-title>
            <source>Atheroscler Suppl</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>30</volume>
            <fpage>271</fpage>
            <page-range>271-277</page-range>
            <pub-id pub-id-type="pmid">29096849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sillevis Smitt</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Albeda</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Van Nierop</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans in a child.</article-title>
            <source>Br J Dermatol</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>289</fpage>
            <page-range>289-91</page-range>
            <pub-id pub-id-type="pmid">1390175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans occurring in a split-thickness skin graft.</article-title>
            <source>Dermatol Surg</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>240</fpage>
            <page-range>240-3</page-range>
            <pub-id pub-id-type="pmid">15762223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Dixit</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans in an unusual site.</article-title>
            <source>Int J Dermatol</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>352</fpage>
            <page-range>352-3</page-range>
            <pub-id pub-id-type="pmid">2753595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Kelbel</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Melonakos</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mullard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Seiffert-Sinha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics.</article-title>
            <source>Dermatol Clin</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>393</fpage>
            <page-range>393-404, vii-iii</page-range>
            <pub-id pub-id-type="pmid">21605804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerharz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stadler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Pemphigus vegetans of the Hallopeau type. Detection of pemphigus antibodies with direct and indirect immunofluorescence].</article-title>
            <source>Hautarzt</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>371</fpage>
            <page-range>371-4</page-range>
            <pub-id pub-id-type="pmid">3308773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hietanen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acantholytic cells in pemphigus. A scanning and transmission electron microscopic study.</article-title>
            <source>Acta Odontol Scand</source>
            <year>1982</year>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>257</fpage>
            <page-range>257-73</page-range>
            <pub-id pub-id-type="pmid">6960626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yaeen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>QM</given-names>
              </name>
              <name>
                <surname>Farhana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of Tzanck smear in various erosive, vesicular, and bullous skin lesions.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2015</year>
            <season>Nov-Dec</season>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>381</fpage>
            <page-range>381-6</page-range>
            <pub-id pub-id-type="pmid">26751561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruocco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ruocco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caccavale</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gambardella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lo Schiavo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans of the folds (intertriginous areas).</article-title>
            <source>Clin Dermatol</source>
            <year>2015</year>
            <season>Jul-Aug</season>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>471</fpage>
            <page-range>471-6</page-range>
            <pub-id pub-id-type="pmid">26051064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kitazawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Danno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sugie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Machizuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugiura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Uehara</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans with oesophageal involvement: successful treatment with minocycline and nicotinamide.</article-title>
            <source>Br J Dermatol</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>132</volume>
            <issue>4</issue>
            <fpage>668</fpage>
            <page-range>668-70</page-range>
            <pub-id pub-id-type="pmid">7748766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavakolpour</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?</article-title>
            <source>Int Immunopharmacol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>53</volume>
            <fpage>133</fpage>
            <page-range>133-142</page-range>
            <pub-id pub-id-type="pmid">29107213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Son</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>The neumann type of pemphigus vegetans treated with combination of dapsone and steroid.</article-title>
            <source>Ann Dermatol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>Suppl 3</issue>
            <fpage>S310</fpage>
            <page-range>S310-3</page-range>
            <pub-id pub-id-type="pmid">22346265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greenberger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samuelov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lyakhovitsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.</article-title>
            <source>Eur J Dermatol</source>
            <year>2012</year>
            <season>Jan-Feb</season>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-7</page-range>
            <pub-id pub-id-type="pmid">22266247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mustafi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maity</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pulse therapy: Opening new vistas in treatment of pemphigus.</article-title>
            <source>J Family Med Prim Care</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>793</fpage>
            <page-range>793-798</page-range>
            <pub-id pub-id-type="pmid">31041203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferraccioli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gremese</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>B cell activating factor (BAFF) and BAFF receptors: fakes and facts.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>190</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-292</page-range>
            <pub-id pub-id-type="pmid">28834574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wax</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.</article-title>
            <source>Int Rev Immunol</source>
            <year>2017</year>
            <month>Jan</month>
            <day>02</day>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-19</page-range>
            <pub-id pub-id-type="pmid">28215100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavakolpour</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tavakolpour</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Interleukin 4 inhibition as a potential therapeutic in pemphigus.</article-title>
            <source>Cytokine</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>77</volume>
            <fpage>189</fpage>
            <page-range>189-95</page-range>
            <pub-id pub-id-type="pmid">26440137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gaestel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mo Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.</article-title>
            <source>J Invest Dermatol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-76</page-range>
            <pub-id pub-id-type="pmid">23657501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>The differential diagnosis of pyostomatitis vegetans and its relation to bowel disease.</article-title>
            <source>Oral Surg Oral Med Oral Pathol</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>363</fpage>
            <page-range>363-73</page-range>
            <pub-id pub-id-type="pmid">6574415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000f6;bel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Management of bullous pemphigoid].</article-title>
            <source>Hautarzt</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>236</fpage>
            <page-range>236-242</page-range>
            <pub-id pub-id-type="pmid">30874841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000e9;bert</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Bullous pemphigoid, a dermatosis of the elderly].</article-title>
            <source>Rev Prat</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>1080</fpage>
            <page-range>1080-1083</page-range>
            <pub-id pub-id-type="pmid">30512605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r35">
          <label>35</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Aslanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yarrarapu</surname>
                <given-names>SNS</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>IgA Pemphigus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">30085605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Rubins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Septe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rubins</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hailey-Hailey disease: a diagnostic challenge.</article-title>
            <source>Cutis</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>157</fpage>
            <page-range>157-159</page-range>
            <pub-id pub-id-type="pmid">31039223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kutlubay</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>&#x000c7;elik</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Serdaro&#x0011f;lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>T&#x000fc;z&#x000fc;n</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Hailey-Hailey disease: A fold (intertriginous) dermatosis.</article-title>
            <source>Clin Dermatol</source>
            <year>2015</year>
            <season>Jul-Aug</season>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>452</fpage>
            <page-range>452-5</page-range>
            <pub-id pub-id-type="pmid">26051060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Me&#x0015f;in&#x00103;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vasile</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mogoant&#x00103;</surname>
                <given-names>S&#x0015e;</given-names>
              </name>
              <name>
                <surname>Ciurea</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>P&#x000e2;rv&#x00103;nescu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dumitrescu</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Georgescu</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Ciobanu</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pyoderma vegetans of the posterior area of the neck: case presentation.</article-title>
            <source>Rom J Morphol Embryol</source>
            <year>2015</year>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>563</fpage>
            <page-range>563-8</page-range>
            <pub-id pub-id-type="pmid">26193230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivollier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vaillant</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Machet</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Huttenberger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lorette</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2001</year>
            <month>May</month>
            <volume>128</volume>
            <issue>5</issue>
            <fpage>644</fpage>
            <page-range>644-8</page-range>
            <pub-id pub-id-type="pmid">11427801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sapadin</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>5 Pt 2</issue>
            <fpage>867</fpage>
            <page-range>867-71</page-range>
            <pub-id pub-id-type="pmid">9810918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vorobyev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and diagnosis of epidermolysis bullosa acquisita.</article-title>
            <source>Expert Rev Clin Immunol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-169</page-range>
            <pub-id pub-id-type="pmid">27580464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulat</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lugovi&#x00107;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Situm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buljan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bradi&#x00107;</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Porphyria cutanea tarda as the most common porphyria.</article-title>
            <source>Acta Dermatovenerol Croat</source>
            <year>2007</year>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-63</page-range>
            <pub-id pub-id-type="pmid">18093456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Handler</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Handler</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Stephany</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Handler</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Porphyria cutanea tarda: an intriguing genetic disease and marker.</article-title>
            <source>Int J Dermatol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>e106</fpage>
            <page-range>e106-e117</page-range>
            <pub-id pub-id-type="pmid">28321838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahoney</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Rothenberger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.</article-title>
            <source>J Clin Invest</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>103</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-8</page-range>
            <pub-id pub-id-type="pmid">10021453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nizamoglu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Frew</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Gerrish</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shelly</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Philp</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>El-Muttardi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dziewulski</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.</article-title>
            <source>Burns</source>
            <year>2018</year>
            <month>May</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>603</fpage>
            <page-range>603-611</page-range>
            <pub-id pub-id-type="pmid">29029855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCullough</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garner</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.</article-title>
            <source>Burns</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>200</fpage>
            <page-range>200-205</page-range>
            <pub-id pub-id-type="pmid">27554629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kavala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Topalo&#x0011f;lu Demir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zindanci</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Can</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Turko&#x0011f;lu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zemheri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cam</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Teksen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal Pap smear findings.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>655</fpage>
            <page-range>655-9</page-range>
            <pub-id pub-id-type="pmid">26194705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adriano</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Gomes Neto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamester</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Di Giunta</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans induced by use of enalapril.</article-title>
            <source>An Bras Dermatol</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>1197</fpage>
            <page-range>1197-200</page-range>
            <pub-id pub-id-type="pmid">22281913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bastiaens</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Zwan</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Verschueren</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Stoof</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Nieboer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Three cases of pemphigus vegetans: induction by enalapril--association with internal malignancy.</article-title>
            <source>Int J Dermatol</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>168</fpage>
            <page-range>168-71</page-range>
            <pub-id pub-id-type="pmid">8169014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56921.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Downie</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dicostanzo</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>5 Pt 2</issue>
            <fpage>872</fpage>
            <page-range>872-5</page-range>
            <pub-id pub-id-type="pmid">9810919</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
